MA vs OGEN · P/E 38, rev $32.79B vs rev $37.7K
Mastercard Inc (MA) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
MA currently screens at market cap $515.12B and trailing P/E 38.4. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the MA and OGEN stock pages for the full models.
Not investment advice.